Biostatistics TRIZ Cases

This case uses trained models to map oligonucleotide sequences to biophysical effects and refine candidates before laboratory testing.

AlphaFold structure ensembles and fitness feedback guide protein sequences toward native-like folding, solubility, and expression.

Intermediate feature updates align predictions with density maps, enabling diverse 3D structures for drug and material development.

Structural features, docking, and molecular dynamics support accurate HLA-allele-specific peptide prediction without large cellular inputs.

Physics-enhanced federated graphs coordinate cross-institutional biological analysis while keeping sensitive data local and protected.

Whole-protein sequence comparison narrows a 20,000-protein search to fewer than 400 without requiring known pocket structures.

An artificial neural network ranks RNA chemical modifications to balance therapeutic effect, in vivo stability, and off-target effects.

Multiple-wavelength optical responses and neural networks measure oxygen saturation, hematocrit, and hemoglobin across variable conduits.

A pre-trained model uses TFO and TTS sequence, structural, and biophysical features to estimate binding affinity faster than experiments.

This case uses whole-protein similarity and multiple sequence alignment to reduce computational cost in off-target detection.

Preliminary screening routes only needed samples to deeper microorganism analysis.

Deep learning embeddings improve variant calling accuracy in low-coverage sequencing data.

A penalized classification model combines rare variant burden scores to detect disorder predisposition with smaller cohorts.

This case calculates separate linear-range and logarithmic lower-limit parameters to visualize complete particle populations.

A trained neural network separates recurrent sequencing errors from true variants, improving variant calling accuracy.